- Home
- FBRX vs MIY Comparison
FBRX vs MIY Comparison
Compare FBRX & MIY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBRX | MIY |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.3M | 354.5M |
| IPO Year | 2017 | 1994 |
Fundamental Metrics
Financial Performance| Metric | FBRX | MIY |
|---|---|---|
| Price | $24.09 | $12.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $67.00 | N/A |
| AVG Volume (30 Days) | ★ 196.5K | 51.2K |
| Earning Date | 03-31-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.91 | $10.57 |
| 52 Week High | $35.62 | $12.90 |
Technical Indicators
Market Signals| Indicator | FBRX | MIY |
|---|---|---|
| Relative Strength Index (RSI) | 38.79 | 41.49 |
| Support Level | $21.94 | $11.39 |
| Resistance Level | $32.40 | $12.40 |
| Average True Range (ATR) | 2.65 | 0.32 |
| MACD | -0.05 | -0.04 |
| Stochastic Oscillator | 26.15 | 29.82 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About MIY Blackrock MuniYield Michigan Quality Fund Inc.
Blackrock Muniyield Michigan Quality Fund Inc is a closed end fund. Its investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.